LOCALLY ADVANCED (UNRESECTABLE) OR METASTATIC SOLID TUMORS
Clinical trials for LOCALLY ADVANCED (UNRESECTABLE) OR METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED (UNRESECTABLE) OR METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED (UNRESECTABLE) OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug NEOK001 targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis early-phase trial tests a new drug called NEOK001 in people with advanced solid tumors that have stopped responding to standard treatments. NEOK001 is designed to deliver a cancer-killing agent directly to tumor cells by targeting two specific proteins. The study will first …
Matched conditions: LOCALLY ADVANCED (UNRESECTABLE) OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: NEOK Bio, Inc. • Aim: Disease control
Last updated Jun 23, 2026 22:04 UTC
-
New Two-Antibody cocktail takes on Hard-to-Treat HER2 cancers
Disease control Recruiting nowThis Phase 2 study is testing a combination of two experimental antibodies (SSGJ-705 and SSGJ-612), with or without chemotherapy, in people with advanced HER2-expressing solid tumors that cannot be removed by surgery or have spread. The goal is to see if the treatment can shrink …
Matched conditions: LOCALLY ADVANCED (UNRESECTABLE) OR METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated Jun 23, 2026 11:59 UTC
-
New drug aims to shrink hard-to-treat tumors
Disease control Recruiting nowThis study tests an experimental drug called NEOK002 in people with advanced solid tumors that have spread and cannot be removed by surgery. The drug is designed to target two proteins on cancer cells to deliver a toxic payload. The study has two parts: first, finding the safest …
Matched conditions: LOCALLY ADVANCED (UNRESECTABLE) OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: NEOK Bio, Inc. • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New drug IBI343 takes on advanced cancers in first human trial
Disease control Recruiting nowThis early-phase study tests a new drug called IBI343 in people with advanced solid tumors that cannot be removed by surgery or have spread. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 470 participants will take part in mul…
Matched conditions: LOCALLY ADVANCED (UNRESECTABLE) OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC